Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection

Anaerobe

Volumn 53, Issue , 2018, Pages 64-73

  Seekatz, Anna M ^a   Theriot, Casey M ^a,b   Rao, Krishna ^a   Chang, Yu Ming ^a   Freeman, Alison E ^a,c   Kao, John Y ^a   Young, Vincent B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Bile acids; Fecal microbiota transplantation; Gut microbiota; Human microbiome; Short chain fatty acids

Indexed keywords

ACETIC ACID; BUTYRIC ACID; DEOXYCHOLIC ACID; LITHOCHOLIC ACID; PROPIONIC ACID; RNA 16S; BACTERIAL RNA; BILE ACID; VOLATILE FATTY ACID;

16S RRNA GENE; ARTICLE; BACTERIAL COLONIZATION; BILE ACID METABOLISM; CLINICAL ARTICLE; CLOSTRIDIALES; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY STRUCTURE; CONTROLLED STUDY; FATTY ACID METABOLISM; FECAL MICROBIOTA TRANSPLANTATION; GENE SEQUENCE; HUMAN; LACHNOSPIRACEAE; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MICROBIAL COMMUNITY; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; RECURRENT INFECTION; RUMINOCOCCACEAE; ADULT; AGED; CLOSTRIDIUM INFECTION; DNA SEQUENCE; FEMALE; GENETICS; INTESTINE FLORA; LONGITUDINAL STUDY; MALE; METABOLISM; METABOLOMICS; MIDDLE AGED; PROCEDURES; SECONDARY PREVENTION; YOUNG ADULT;

ADULT; AGED; BILE ACIDS AND SALTS; CLOSTRIDIUM INFECTIONS; FATTY ACIDS, VOLATILE; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLOMICS; MIDDLE AGED; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; SECONDARY PREVENTION; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 85045908393     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2018.04.001     Document Type: Article

References (56)

1. Lessa, F.C., Mu, Y., Bamberg, W.M., Beldavs, Z.G., Dumyati, G.K., Dunn, J.R., Farley, M.M., Holzbauer, S.M., Meek, J.I., Phipps, E.C., Wilson, L.E., Winston, L.G., Cohen, J.A., Limbago, B.M., Fridkin, S.K., Gerding, D.N., McDonald, L.C., Burden of Clostridium difficile infection in the United States. N. Engl. J. Med. 372 (2015), 825–834.
2. Cornely, O.A., Miller, M.A., Louie, T.J., Crook, D.W., Gorbach, S.L., Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin. Infect. Dis. 55:Suppl 2 (2012), S154–S161.
3. Loo, V.G., Bourgault, A.-M., Poirier, L., Lamothe, F., Michaud, S., Turgeon, N., Toye, B., Beaudoin, A., Frost, E.H., Gilca, R., Brassard, P., Dendukuri, N., Béliveau, C., Oughton, M., Brukner, I., Dascal, A., Host and pathogen factors for Clostridium difficile infection and colonization. N. Engl. J. Med. 365 (2011), 1693–1703.
4. Chang, J.Y., Antonopoulos, D.A., Kalra, A., Tonelli, A., Khalife, W.T., Schmidt, T.M., Young, V.B., Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J. Infect. Dis. 197 (2008), 435–438.
5. Seekatz, A.M., Rao, K., Santhosh, K., Young, V.B., Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection. Genome Med. 8 (2016), 1–11.
6. Cammarota, G., Ianiro, G., Gasbarrini, A., Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J. Clin. Gastroenterol. 48 (2014), 693–702.
7. Seekatz, A.M., Aas, J., Gessert, C.E., Rubin, T.A., Saman, D.M., Bakken, J.S., Young, V.B., Recovery of the gut microbiome following fecal microbiota transplantation. mBio, 5, 2014 e00893–14.
8. Hamilton, M.J., Weingarden, A.R., Unno, T., Khoruts, A., Sadowsky, M.J., High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microb. 4 (2013), 125–135.
9. Song, Y., Garg, S., Girotra, M., Maddox, C., von Rosenvinge, E.C., Dutta, A., Dutta, S., Fricke, F.W., Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PLoS One, 8, 2013 e81330.
10. van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E.G., de Vos, W.M., Visser, C.E., Kuijper, E.J., Bartelsman, J.F., Tijssen, J.G., Speelman, P., Dijkgraaf, M.G., Keller, J.J., Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368 (2013), 407–415.
11. Jalanka, J., Mattila, E., Jouhten, H., Hartman, J., de Vos, W.M., Arkkila, P., Satokari, R., Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection. BMC Med., 14, 2016, 155.
12. Britton, R.A., Young, V.B., Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol. 20 (2012), 313–319.
13. Theriot, C.M., Bowman, A.A., Young, V.B., Ellermeier, C.D., Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile Spore germination and outgrowth in the large intestine. mSphere, 1, 2016 e00045–15.
14. Wilson, K.H., Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination. J. Clin. Microbiol. 18 (1983), 1017–1019.
15. Sorg, J.A., Sonenshein, A.L., Bile salts and glycine as cogerminants for Clostridium difficile spores. J. Bacteriol. 190 (2008), 2505–2512.
16. Giel, J.L., Sorg, J.A., Sonenshein, A.L., Zhu, J., Metabolism of bile salts in mice influences spore germination in Clostridium difficile. PLoS One, 5, 2010 e8740.
17. Thanissery, R., Winston, J.A., Theriot, C.M., Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids. Anaerobe, 2017, 10.1016/j.anaerobe.2017.03.004.
18. Theriot, C.M., Koenigsknecht, M.J., Carlson, P.E. Jr., Hatton, G.E., Nelson, A.M., Li, B., Huffnagle, G.B., J, Z.L., Young, V.B., Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat. Commun., 5, 2014, 3114.
19. Ridlon, J.M., Kang, D.J., Hylemon, P.B., Isolation and characterization of a bile acid inducible 7alpha-dehydroxylating operon in Clostridium hylemonae TN271. Anaerobe 16 (2010), 137–146.
20. Buffie, C.G., Bucci, V., Stein, R.R., McKenney, P.T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., Littmann, E., van den Brink, M.R., Jenq, R.R., Taur, Y., Sander, C., Cross, J.R., Toussaint, N.C., Xavier, J.B., Pamer, E.G., Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517 (2015), 205–208.
21. Weingarden, A.R., Chen, C., Bobr, A., Yao, D., Lu, Y., Nelson, V.M., Sadowsky, M.J., Khoruts, A., Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am. J. Physiol. Gastrointest. Liver Physiol. 306 (2014), G310–G319.
22. Studer, N., Desharnais, L., Beutler, M., Brugiroux, S., Terrazos, M.A., Menin, L., Schurch, C.M., McCoy, K.D., Kuehne, S.A., Minton, N.P., Stecher, B., Bernier-Latmani, R., Hapfelmeier, S., Functional intestinal bile acid 7alpha-dehydroxylation by Clostridium scindens associated with protection from Clostridium difficile infection in a gnotobiotic mouse model. Front Cell Infect Microbiol, 6, 2016, 191.
23. Lawley, T.D., Clare, S., Walker, A.W., Stares, M.D., Connor, T.R., Raisen, C., Goulding, D., Rad, R., Schreiber, F., Brandt, C., Deakin, L.J., Pickard, D.J., Duncan, S.H., Flint, H.J., Clark, T.G., Parkhill, J., Dougan, G., Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog., 8, 2012 e1002995.
24. Staley, C., Vaughn, B.P., Graiziger, C.T., Singroy, S., Hamilton, M.J., Yao, D., Chen, C., Khoruts, A., Sadowsky, M.J., Community dynamics drive punctuated engraftment of the fecal microbiome following transplantation using freeze-dried, encapsulated fecal microbiota. Gut Microb., 2017, 10.1080/19490976.2017.1299310:1–13.
25. Kozich, J.J., Westcott, S.L., Baxter, N.T., Highlander, S.K., Schloss, P.D., Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl. Environ. Microbiol. 79 (2013), 5112–5120.
26. Schloss, P.D., Westcott, S.L., Ryabin, T., Hall, J.R., Hartmann, M., Hollister, E.B., Lesniewski, R.A., Oakley, B.B., Parks, D.H., Robinson, C.J., Sahl, J.W., Stres, B., Thallinger, G.G., Van Horn, D.J., Weber, C.F., Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75 (2009), 7537–7541.
27. Edgar, R.C., Haas, B.J., Clemente, J.C., Quince, C., Knight, R., UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27 (2011), 2194–2200.
28. Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., Peplies, J., Glockner, F.O., The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41 (2013), D590–D596.
29. Wang, Q., Garrity, G.M., Tiedje, J.M., Cole, J.R., Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73 (2007), 5261–5267.
30. Warnes, G.R., Bolker, B., Bonebakker, L., Gentleman, R., Liaw, W.H.A., Lumley, T., Maechler, M., Magnusson, A., Moeller, S., Schwartz, M., Venables, B., Gplots: Various R Programming Tools for Plotting Data (v2.12.1). 2013 Accessed Dec 2015 http://cran.r-project.org/web/packages/gplots/gplots.pdf.
31. Stamatakis, A., RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30 (2014), 1312–1313.
32. Schliep, K., Paradis, E., de Oliveira Martins, L., Potts, A., White, T.W., Stachniss, C., Kendall, M., Phylogenetic analysis in R: Estimation of phylogenetic trees and networks using maximum likelihood, maximum parsimony, distance methods and Hadamard conjugation (v2.2.0). 2017 https://github.com/KlausVigo/phangorn. (Accessed 4 May 2017)
33. Revell, L.J., Phytools: Phylogenetic tools for comparative biology (and other things) (v0.6-00). 2017 http://github.com/liamrevell/phytools. (Accessed 4 May 2017)
34. Wickham, H., Plyr: Tools for splitting, applying and combining data (v1.8.4). 2016 http://had.co.nz/plyr https://github.com/hadley/plyr. (Accessed 30 April 2017)
35. Wickham, H., Francois, R., Dplyr: a grammar of data manipulation. github.Com/hadley/dplyr. 2016 Accessed Dec 2016.
36. Oksanen, J., Blanchet, F.G., Kindt, R., Legendre, P., Minchin, P.R., O'Hara, R.B., Simpson, G.L., Solymos, P., Stevens, M.H.H., Wagner, H., Community Ecology Package, v2.0-10. 2013 Accessed Dec 2014 http://CRAN.R-poject.org/package=vegan.
37. Hojsgaard, S., Halekoh, U., Yan, J., Package 'Geepack': Generalized Estimating Equation Package. 2014 Accessed Jan 2016 https://cran.r-project.org/web/packages/geepack/geepack.pdf.
38. Pan, W., Akaike's information criterion in generalized estimating equations. Biometrics 57 (2001), 120–125.
39. Bakken, J.S., Borody, T., Brandt, L.J., Brill, J.V., Demarco, D.C., Franzos, M.A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L.P., Moore, T.A., Russell, G., Surawicz, C., Treating Clostridium difficile infection with fecal microbiota transplantation. Clin. Gastroenterol. Hepatol. 9 (2011), 1044–1049.
40. Kelly, C.R., Khoruts, A., Staley, C., Sadowsky, M.J., Abd, M., Alani, M., Bakow, B., Curran, P., McKenney, J., Tisch, A., Reinert, S.E., Machan, J.T., Brandt, L.J., Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial. Ann. Intern. Med. 165 (2016), 609–616.
41. Liang, K.-Y., Zeger, S.L., Longitudinal data analysis using generalized linear models. Biometrika 73 (1986), 13–22.
42. Ridlon, J.M., Kang, D.J., Hylemon, P.B., Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47 (2006), 241–259.
43. Devlin, A.S., Fischbach, M.A., A biosynthetic pathway for a prominent class of microbiota-derived bile acids. Nat. Chem. Biol. 11 (2015), 685–690.
44. Ott, S.J., Waetzig, G.H., Rehman, A., Moltzau-Anderson, J., Bharti, R., Grasis, J.A., Cassidy, L., Tholey, A., Fickenscher, H., Seegert, D., Rosenstiel, P., Schreiber, S., Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection. Gastroenterology 152 (2017), 799–811 e7.
45. Peng, L., Li, Z.R., Green, R.S., Holzman, I.R., Lin, J., Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J. Nutr. 139 (2009), 1619–1625.
46. Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., Takahashi, M., Fukuda, N.N., Murakami, S., Miyauchi, E., Hino, S., Atarashi, K., Onawa, S., Fujimura, Y., Lockett, T., Clarke, J.M., Topping, D.L., Tomita, M., Hori, S., Ohara, O., Morita, T., Koseki, H., Kikuchi, J., Honda, K., Hase, K., Ohno, H., Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504 (2013), 446–450.
47. Rivera-Chavez, F., Zhang, L.F., Faber, F., Lopez, C.A., Byndloss, M.X., Olsan, E.E., Xu, G., Velazquez, E.M., Lebrilla, C.B., Winter, S.E., Baumler, A.J., Depletion of butyrate-producing clostridia from the gut microbiota drives an aerobic luminal expansion of Salmonella. Cell Host Microbe 19 (2016), 443–454.
48. Antharam, V.C., Li, E.C., Ishmael, A., Sharma, A., Mai, V., Rand, K.H., Wang, G.P., Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J. Clin. Microbiol. 51 (2013), 2884–2892.
49. Khanna, S., Pardi, D.S., Kelly, C.R., Kraft, C.S., Dhere, T., Henn, M.R., Lombardo, M.J., Vulic, M., Ohsumi, T., Winkler, J., Pindar, C., McGovern, B.H., Pomerantz, R.J., Aunins, J.G., Cook, D.N., Hohmann, E.L., A novel microbiome therapeutic increases gut microbial diversity and prevents recurrent Clostridium difficile infection. J. Infect. Dis. 214 (2016), 173–181.
50. Mullard, A., Leading microbiome-based therapeutic falters in Phase II trial. Nat. Rev. Drug Discov., 15, 2016, 595.
51. Staley, C., Kelly, C.R., Brandt, L.J., Khoruts, A., Sadowsky, M.J., Complete microbiota engraftment is not essential for recovery from recurrent Clostridium difficile infection following fecal microbiota transplantation. mBio, 7, 2016.
52. Lee, S.T.M., Kahn, S.A., Delmont, T.O., Shaiber, A., Esen, O.C., Hubert, N.A., Morrison, H.G., Antonopoulos, D.A., Rubin, D.T., Eren, A.M., Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics. Microbiome, 5, 2017, 50.
53. Li, S.S., Zhu, A., Benes, V., Costea, P.I., Hercog, R., Hildebrand, F., Huerta-Cepas, J., Nieuwdorp, M., Salojarvi, J., Voigt, A.Y., Zeller, G., Sunagawa, S., de Vos, W.M., Bork, P., Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 352 (2016), 586–589.
54. Goodman, A.L., Kallstrom, G., Faith, J.J., Reyes, A., Moore, A., Dantas, G., Gordon, J.I., Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 6252–6257.
55. Seedorf, H., Griffin, N.W., Ridaura, V.K., Reyes, A., Cheng, J., Rey, F.E., Smith, M.I., Simon, G.M., Scheffrahn, R.H., Woebken, D., Spormann, A.M., Van Treuren, W., Ursell, L.K., Pirrung, M., Robbins-Pianka, A., Cantarel, B.L., Lombard, V., Henrissat, B., Knight, R., Gordon, J.I., Bacteria from diverse habitats colonize and compete in the mouse gut. Cell 159 (2014), 253–266.
56. Ericsson, A.C., Personett, A.R., Turner, G., Dorfmeyer, R.A., Franklin, C.L., Variable colonization after reciprocal fecal microbiota transfer between mice with low and high richness microbiota. Front. Microbiol., 8, 2017, 196.